Scientists are beginning to understand more about how certain psychedelic drugs may help people recover from severe trauma.
A new study suggests that these drugs may repair important structures in the brain that are damaged by stress-related disorders such as post‑traumatic stress disorder (PTSD).
The research, published in the scientific journal Biological Psychiatry, offers new clues about why psychedelic‑assisted treatments may produce long‑lasting improvements in mental health.
PTSD is a serious mental health condition that can develop after someone experiences or witnesses a traumatic event. These events may include war, violence, accidents, or natural disasters.
People with PTSD often suffer from intense memories of the traumatic event, nightmares, anxiety, and a constant feeling of danger. Their brains may remain stuck in a state of fear even when they are safe.
Scientists have long known that PTSD affects how different parts of the brain communicate with each other. Brain networks that normally work together smoothly can become poorly coordinated. This can make it harder for the brain to process memories, control emotions, and respond calmly to stress.
In recent years, researchers have studied psychedelic drugs such as psilocybin and MDMA as possible treatments for PTSD. Psilocybin is the main psychoactive compound found in certain mushrooms, while MDMA is sometimes known as ecstasy.
In carefully controlled medical settings, these substances have shown promise in helping patients process traumatic memories and reduce symptoms of anxiety and fear.
However, scientists have not fully understood how these drugs create long‑lasting improvements. The effects of the drugs themselves usually last only a few hours, but many patients report benefits that continue for months. The new study suggests that an important clue may lie in a substance in the brain called myelin.
Myelin is a protective layer that wraps around nerve fibers. It acts like insulation around electrical wires. By insulating nerve cells, myelin allows signals to travel quickly and efficiently through the brain. Healthy myelin is essential for proper communication between brain regions.
Damage to myelin can disrupt this communication. When signals move too slowly or become poorly coordinated, brain networks may stop working in harmony. Some scientists believe that chronic stress and trauma can harm myelin, contributing to the symptoms seen in PTSD.
The research team used rats to explore whether psychedelic drugs could influence myelin in the brain. The animals were placed in a laboratory model that mimics fear learning, which is often used to study PTSD. In this model, animals learn to associate certain environments with danger and develop anxiety‑like behavior.
After this conditioning process, the researchers treated the rats with repeated low doses of psilocybin or MDMA. They then observed how the animals behaved and studied changes in their brains.
The results were striking. Rats that received the psychedelic treatments showed less anxiety‑like behavior and explored their surroundings more freely. These changes suggested that their fear responses had become less intense.
When scientists examined the animals’ brains, they found important biological changes. Cells called oligodendrocytes became more active. These cells are responsible for producing myelin. The researchers discovered signs that myelin in a part of the brain called the dentate gyrus was being repaired and remodeled.
The dentate gyrus is located within the hippocampus, a brain structure that plays a central role in learning and memory. This region helps the brain organize memories and distinguish between safe and dangerous situations.
The scientists wanted to know whether myelin repair was simply associated with behavioral improvements or whether it was necessary for recovery. To test this, they carried out additional experiments. In some animals they damaged the myelin layer, while in others they enhanced the process that creates new myelin.
Using powerful microscopes and genetic analysis, the researchers confirmed that psilocybin and MDMA directly stimulated myelin repair.
When the team blocked a key serotonin receptor in the brain called 5‑HT2A, both the behavioral improvements and the myelin changes disappeared. This suggests that the drugs trigger these effects through specific brain signaling pathways.
The researchers also tested another drug called anisomycin, which blocks the formation of fear memories. Although this treatment reduced anxiety behaviors, it did not repair myelin.
This result showed that simply weakening traumatic memories was not enough to restore healthy brain function. Structural repair of myelin appeared to be a crucial part of long‑term recovery.
The study also revealed another helpful effect. Psilocybin and MDMA reduced the activity of astrocytes that can trigger inflammation in the brain. Lower inflammation may further support healing and improved brain communication.
Experts say this discovery may change how scientists think about psychedelic therapies. In the past, most research focused on neurons, the main nerve cells of the brain. The new findings highlight the important role of other brain cells, particularly oligodendrocytes, which produce myelin and support healthy brain signaling.
Researchers believe that psychedelic drugs may temporarily open a period of increased brain flexibility, sometimes described as a “window of plasticity.” During this time, the brain becomes more able to reorganize its connections. Myelin repair may help stabilize these new and healthier patterns of brain activity after the drug’s immediate effects fade.
The authors emphasize that psychedelic treatments would not replace psychotherapy. Instead, these medicines may help create the right conditions for therapy to work better. By improving communication across brain networks, the brain may be able to integrate new experiences and healthier emotional responses.
Although the study was performed in rats, it provides important clues about how these treatments might work in humans. Future research will need to confirm whether similar biological processes occur in people receiving psychedelic‑assisted therapy.
Overall, the findings suggest that repairing the brain’s insulation system could play a key role in lasting recovery from trauma. If further studies confirm these results, therapies that support myelin repair could strengthen the long‑term benefits of psychedelic treatments for PTSD and other stress‑related disorders.
If you care about health, please read studies that scientists find a core feature of depression and this metal in the brain strongly linked to depression.
For more health information, please see recent studies about drug for mental health that may harm the brain, and results showing this therapy more effective than ketamine in treating severe depression.
The research was published in the journal Biological Psychiatry.
Copyright © 2026 Knowridge Science Report. All rights reserved.
